<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND:: Administrative health care claims data are used for epidemiologic, health services, and outcomes <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> research and thus play a significant role in policy </plain></SENT>
<SENT sid="1" pm="."><plain><z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">Cancer</z:e> stage, which is often a major driver of cost and clinical outcomes, is not typically included in claims data </plain></SENT>
<SENT sid="2" pm="."><plain>OBJECTIVES:: Evaluate algorithms used in a dataset of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> patients to identify patients with metastatic breast (BC), lung (LC), or colorectal (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> using claims data </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS:: Clinical data on BC, LC, or <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> patients (between January 1, 2007 and March 31, 2010) were linked to a health care claims database </plain></SENT>
<SENT sid="4" pm="."><plain>Inclusion required health plan enrollment â‰¥3 months before initial <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> diagnosis date </plain></SENT>
<SENT sid="5" pm="."><plain>Algorithms were used in the claims database to identify patients' disease status, which was compared with physician-reported <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastases</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>Generic and <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e>-specific algorithms were evaluated using <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e>-9 codes, varying diagnosis time frames, and including/excluding other <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>Positive and negative predictive values, sensitivity, and specificity were assessed </plain></SENT>
<SENT sid="8" pm="."><plain>RESULTS:: The linked databases included 14,480 patients; of whom, 32%, 17%, and 14.2% had metastatic BC, LC, and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>, respectively, at diagnosis and met inclusion criteria </plain></SENT>
<SENT sid="9" pm="."><plain>Nontumor-specific algorithms had lower specificity than <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e>-specific algorithms </plain></SENT>
<SENT sid="10" pm="."><plain><z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">Tumor</z:e>-specific algorithms' sensitivity and specificity were 53% and 99% for BC, 55% and 85% for LC, and 59% and 98% for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>, respectively </plain></SENT>
<SENT sid="11" pm="."><plain>CONCLUSIONS:: Algorithms to distinguish metastatic BC, LC, and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> from locally advanced disease should use <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e>-specific primary <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> codes with 2 claims for the specific primary <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> &gt;30-42 days apart to reduce misclassification </plain></SENT>
<SENT sid="12" pm="."><plain>These performed best overall in specificity, positive predictive values, and overall accuracy to identify <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastatic cancer</z:e> in a health care claims database </plain></SENT>
</text></document>